State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
- 31 December 2004
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 64 (6), 1081-1088
- https://doi.org/10.1016/j.urology.2004.07.031
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Long-term Safety and Efficacy of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaJournal of Urology, 2003
- Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension StudyEuropean Urology, 2002
- Efficacy and Safety of a New Prolonged Release Formulation of Alfuzosin 10 mg Once Daily versus Alfuzosin 2.5 mg Thrice Daily and Placebo in Patients with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2000
- A SECOND PHASE III MULTICENTER PLACEBO CONTROLLED STUDY OF 2 DOSAGES OF MODIFIED RELEASE TAMSULOSIN IN PATIENTS WITH SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1998
- Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)British Journal of Urology, 1997
- Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive PatientsJournal of Urology, 1997
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- Long‐term treatment of benign prostatic hyperplasia with alfuzosin: a 24–30 month surveyBritish Journal of Urology, 1994
- AlfuzosinDrugs, 1993
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993